Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
59.6% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
24
users have liked this narrative
6
users have commented on this narrative
55
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.9% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
31
users have liked this narrative
6
users have commented on this narrative
87
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.8% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
13
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Silgan Holdings
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Macroeconomic Headwinds And Acquisition Risks Will Shape US Packaging Prospects
Key Takeaways Potential macroeconomic challenges and slowdowns in product launches may hinder the company's optimistic revenue growth forecast for 2025. Acquisition reliance and increased financial burdens might strain profit margins, posing risks to earnings and free cash flow projections.
View narrative
US$47.00
FV
0.8% undervalued
intrinsic discount
3.75%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
Vertex
AN
AnalystLowTarget
Consensus Narrative from 13 Analysts
Growing ERP Competition And Escalating Regulations Will Hinder Progress
Key Takeaways Increasing competition and industry consolidation threaten Vertex’s revenue growth, customer retention, and ability to command premium pricing in a commoditizing market. Rising regulatory demands and heavy investment in AI and development are pressuring profit margins and hindering sustainable earnings improvement.
View narrative
US$31.00
FV
11.3% undervalued
intrinsic discount
16.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
Murphy Oil
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
Eagle Ford Underperformance And Gulf Disruptions Will Weaken Outlook
Key Takeaways High development costs in offshore projects and operational execution issues may compress margins and affect earnings. Market exposure and Gulf production disruptions present volatility and operational challenges impacting revenue growth projections.
View narrative
US$23.00
FV
0.6% undervalued
intrinsic discount
-1.23%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
Inspire Medical Systems
AN
AnalystLowTarget
Consensus Narrative from 14 Analysts
Mounting Sleep Apnea Costs Will Stall Progress Yet Spur Renewal
Key Takeaways Rising healthcare cost pressures, regulatory hurdles, and competition from lower-cost alternatives threaten Inspire’s revenue growth, pricing power, and international expansion opportunities. Heavy reliance on the flagship device exposes Inspire to revenue risks if alternative sleep apnea treatments gain traction or device outcomes disappoint stakeholders.
View narrative
US$149.00
FV
48.3% undervalued
intrinsic discount
16.35%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
Nextracker
AN
AnalystLowTarget
Consensus Narrative from 25 Analysts
Heavy US Reliance Will Expose Risks And Compress Margins
Key Takeaways Heavy reliance on the U.S. market exposes Nextracker to geopolitical risks and policy changes, potentially impacting future revenues. Expansion and R&D investments could pressure margins if new ventures do not meet revenue expectations quickly.
View narrative
US$41.88
FV
33.0% overvalued
intrinsic discount
10.01%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
GXO Logistics
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
AI Integration, Healthcare, And Aerospace Wins Will Create Future Opportunity
Key Takeaways Short-term integration risks and customer realignments could affect EBITDA despite strategic growth in health care and aerospace. AI technology and Wincanton acquisition pose initial pressures but promise long-term gains in productivity and expertise.
View narrative
US$44.61
FV
14.2% overvalued
intrinsic discount
3.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
15 days ago
author updated this narrative
Janus Henderson Group
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Passive Investing And Digital Automation Will Squeeze Net Margins
Key Takeaways Ongoing client migration to passive products and digital platforms threatens Janus Henderson’s revenue growth, competitiveness, and long-term retention. Rising technology, compliance, and expansion costs create structural pressure on margins amid industry consolidation and heightened regulatory scrutiny.
View narrative
US$36.00
FV
17.9% overvalued
intrinsic discount
2.47%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
Timken
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Automation Shifts Will Shrink Industrial Markets Despite Renewables
Key Takeaways Rapid technology shifts and sustainability trends threaten traditional product demand, eroding core revenue streams and pressuring long-term profitability. Heightened competition and underinvestment in innovation risk shrinking pricing power and brand differentiation, leading to weaker margins and earnings stability.
View narrative
US$71.46
FV
3.4% overvalued
intrinsic discount
1.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
Pegasystems
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Low-Code Automation And Hyperscaler Alliances Will Erode Margins
Key Takeaways Rising competitive pressure and market shifts threaten Pegasystems' revenue growth, margins, and pricing power, due to new entrants and bundled solutions from larger rivals. Increasing reliance on subscription SaaS, complex deal structures, and the risk of client consolidation may create revenue volatility and reduce future earnings visibility.
View narrative
US$35.93
FV
49.7% overvalued
intrinsic discount
3.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
Value any company in seconds
Popular companies